Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IIOngoingD-0382-2021

Drug recall · May 26, 2021

PremierZen Black 5000 recall

Why: Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil.

Class II: could cause temporary or reversible health problems; serious harm is remote.

The recall

Product

PremierZen Black 5000, packaged in cardboard blisters containing one capsule per card, Distributed by Yolo Studio, Cliffside Park, NJ

Lots / codes

all lots

Quantity
500 cards
Company
Hyobin LLC, Ridgewood, NJ
Distribution
USA Nationwide
Initiated
April 6, 2021 · Voluntary: Firm initiated
Classified
May 14, 2021
Reported
May 26, 2021
How notified
Press Release

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Recalled with it (same recall event)

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.